Efficacy and Safety of Transcranial dIrect Current stiMulation in Multiple System Atrophy-Cerebellar Variant
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-90
SponsorUniversity of Salerno
About this trial
This is a double-blind, randomized, sham-controlled clinical trial that aim to verify the safety and the efficacy of anodal transcranial direct current stimulation (tDCS) cerebellar symptoms in Multiple System Atrophy type C (MSA).
Eligibility criteria
Qualifiers
Multiple system atrophy cerebellar variant according with the Movemente Disorder Society criteria (Wenning et al 2022)
Ability to walk either indipendently or with a minimum support
Disqualifiers
Presence of electrical stimulators (for example, pacemaker, Deep Brain Stimulation, DBS)
Difficult in understanding Italian language
Presence of severe sensory deficits (for example, visual or hearing impairments)
History of drug abuse
Trial design
Treatments tested in this trial
- Anodal transcranial direct current stimulation (a-tDCS)
- Sham stimulation
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov